HPV Vaccination-Reaping the Rewards of the Appliance of Science

BMJ (Online)

Volumn 346, Issue 7907, 2013, Pages

  Barton, Simon ^a   O'Mahony, Colm ^b  

^a Chelsea and Westminster Trust   (United Kingdom)

^b Countess of Chester NHS Trust ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ANTIGEN RECOGNITION; AUSTRALIA; CONDYLOMA ACUMINATUM; DRUG EFFICACY; EDITORIAL; HEAD AND NECK TUMOR; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SERVICE; HERD IMMUNITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION PREVENTION; NONHUMAN; OROPHARYNX CANCER; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SEXUAL HEALTH; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; VACCINATION; VULVA CANCER;

CONDYLOMATA ACUMINATA; FEMALE; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES;

EID: 84878291688     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f2184     Document Type: Editorial

References (7)

1. Ali H, Donovan B, Wand H, Read TRH, Regan DG, Grulich AE, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013;346:f2032.
2. Lanitis T, Carroll S, O'Mahony C, Charman F, Khalid JM, Griffiths V, et al. The cost of managing genital warts in the UK. Int J STD AIDS 2012;23:189-94.
3. O'Mahony C. Government decision on national human papillomavirus vaccine programme is a sad day for sexual health. Sex Transm Infect 2008;84:251.
4. Hammond P. (Not) warts and all. BMJ 2008;337:a2186.
5. D'Souza G, Kreimer AR, Viscidi, R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56. (Pubitemid 46740304)
6. Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 2012;344:e1401.
7. Daayana S, Elkord E, Winters U, Pawlita M, Roden R, Stern PL, et al. Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia. Br J Cancer 2010;102:1129-36.